Investors and Media
Document Details
Form
Filing Date
Oct 8, 2021
Document Date
Oct 8, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
4D Molecular Therapeutics
Issuer
4D MOLECULAR THERAPEUTICS, INC.